MedPath

LIDOCAINE

Approved
Approval ID

d5e2e8c0-48b3-4666-95a2-d9aef29f1a1c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 6, 2019

Manufacturers
FDA

Two Hip Consulting, LLC

DUNS: 965352896

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

LIDOCAINE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code76074-135
Product Classification
G
Generic Name
LIDOCAINE
Product Specifications
Route of AdministrationTOPICAL
Effective DateJanuary 30, 2019
FDA Product Classification

INGREDIENTS (4)

POLYETHYLENE GLYCOL 300Inactive
Code: 5655G9Y8AQ
Classification: IACT
LIDOCAINEActive
Quantity: 5 g in 100 g
Code: 98PI200987
Classification: ACTIB
PEPPERMINT OILInactive
Code: AV092KU4JH
Classification: IACT
POLYETHYLENE GLYCOL 1450Inactive
Code: OJ4Z5Z32L4
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LIDOCAINE - FDA Drug Approval Details